Business Context and Reporting Period
Company: Establishment Labs Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date: February 9, 2021
Context: The Company, incorporated in the British Virgin Islands and listed on the NASDAQ Capital Market under the symbol "ESTA," reported an "Other Event" regarding a virtual investor event.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a current report focused on a corporate event rather than financial performance.
Material Changes
No material financial changes or operational updates were disclosed in this filing. The report solely announces the scheduling of a virtual investor event.
Guidance, Outlook, and Management Commentary
- Event Announcement: The Company hosted a virtual investor event on February 9, 2021, from 1:00 PM to 2:30 PM ET.
- Focus: The discussion centered on the Motiva MIA system for minimally invasive breast augmentation.
- Product Details: The system includes the Ergonomix2 Diamond implant (which received CE mark approval in December 2020) and proprietary tools, specifically the Motiva MIA Inflatable Balloon and the Motiva MIA Injector.
- Legal Disclaimer: Information furnished in this report and the accompanying press release is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the content of the press release (Exhibit 99.1) for specific details on the Motiva MIA system discussed during the event.
- Confirm the CE mark status of the Ergonomix2 Diamond implant as of December 2020.
- Review subsequent filings (e.g., 10-K or 10-Q) for financial impact related to the Motiva MIA system, as this 8-K contains no financial data.